Literature DB >> 14512373

Novel polymorphisms influencing transcription of the human CHRM2 gene in airway smooth muscle.

Anthony G Fenech1, Charlotte K Billington, Caroline Swan, Susan Richards, Therese Hunter, Martin J Ebejer, Alex E Felice, Roger Ellul-Micallef, Ian P Hall.   

Abstract

Muscarinic receptors are a functionally important family of G-protein-coupled receptors. Using a combination of rapid amplification of 5' cDNA ends and reporter gene assays, we characterized the 5' untranslated region of the CHRM2 gene as expressed in human airway smooth muscle (HASM) cells. A splice site is present 46 bp upstream from the ATG start codon. Five exons with alternative splicing patterns are present upstream of this splice site, separated by introns ranging from 87 bp to > 145 kb. There is evidence for the gene being under the control of a TATA-less promoter with Sp1, GATA, and activator protein-2 binding sites. Multiple transcription start sites (TSSs) were identified. We identified a novel 0.5-kb hypervariable region located 648 bp upstream of the most 5' TSS, a multiallelic (CA) tandem repeat 96 bp downstream of the most 5' TSS, and a common C-->A SNP located 136 bp upstream of the most 5' TSS. Functional studies in primary HASM cells and the BEAS-2B cell line demonstrated highest promoter activity to be upstream of the most 3' TSS, with potential repressor elements operating in a cell type-dependent manner, located upstream of the most 5' TSS. We present functional data to show that the CA repeat may influence the transcription of the gene in HASM and BEAS-2B cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14512373     DOI: 10.1165/rcmb.2003-0011OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  8 in total

1.  African-specific variability in the acetylcholine muscarinic receptor M4: association with cocaine and heroin addiction.

Authors:  Orna Levran; Matthew Randesi; Einat Peles; Joel Correa da Rosa; Jurg Ott; John Rotrosen; Miriam Adelson; Mary Jeanne Kreek
Journal:  Pharmacogenomics       Date:  2016-06-07       Impact factor: 2.533

2.  Genetic analysis of adiponectin and obesity in Hispanic families: the IRAS Family Study.

Authors:  Beth S Sutton; Stefanie Weinert; Carl D Langefeld; Adrienne H Williams; Joel K Campbell; Mohammed F Saad; Steven M Haffner; Jill M Norris; Donald W Bowden
Journal:  Hum Genet       Date:  2005-04-21       Impact factor: 4.132

3.  Identification of a microdeletion at the 7q33-q35 disrupting the CNTNAP2 gene in a Brazilian stuttering case.

Authors:  Aline L Petrin; Célia M Giacheti; Luciana P Maximino; Dagma V M Abramides; Sthella Zanchetta; Natalia F Rossi; Antônio Richieri-Costa; Jeffrey C Murray
Journal:  Am J Med Genet A       Date:  2010-12       Impact factor: 2.802

Review 4.  The role of TGF-β in polycystic ovary syndrome.

Authors:  Nazia Raja-Khan; Margrit Urbanek; Raymond J Rodgers; Richard S Legro
Journal:  Reprod Sci       Date:  2013-04-12       Impact factor: 3.060

Review 5.  Pharmacogenetic approaches in the treatment of asthma.

Authors:  Ian Sayers; Ian P Hall
Journal:  Curr Allergy Asthma Rep       Date:  2005-03       Impact factor: 4.919

6.  Pharmacogenomics of pediatric asthma.

Authors:  Sarika Gupta; Shally Awasthi
Journal:  Indian J Hum Genet       Date:  2010-09

7.  Factors Associated with Decisions for Initial Dosing, Up-Titration of Propiverine and Treatment Outcomes in Overactive Bladder Syndrome Patients in a Non-Interventional Setting.

Authors:  Marjan Amiri; Tim Schneider; Matthias Oelke; Sandra Murgas; Martin C Michel
Journal:  J Clin Med       Date:  2021-01-15       Impact factor: 4.241

8.  Exploring the functional role of the CHRM2 gene in human cognition: results from a dense genotyping and brain expression study.

Authors:  Florencia M Gosso; Eco J C de Geus; Tinca J C Polderman; Dorret I Boomsma; Danielle Posthuma; Peter Heutink
Journal:  BMC Med Genet       Date:  2007-11-08       Impact factor: 2.103

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.